NHS Framework Agreement, Branded Medicines for London and South of England
Estimated value
—
goods
Awarded value
—
Suppliers
114
28 SME
Lots
6
114 awarded
Published
17 Sept 2021
Total lots
6
Awarded
6
0 pending
Estimated total
—
Awarded total
—
Lot 1cancelled
CM/PHR/20/5598/01 - NHS Framework LONDON Branded Medicines - Tranche B.
Award value
—
Start
31 Aug 2021
End
31 Aug 2023
Estimated
—
CPV
33600000
Awarded to 27 suppliers
BI
IP
Lot 4cancelled
CM/PHR/20/5598/04- NHS Framework SOUTH of England - Tranche B.
Award value
—
Start
31 Aug 2021
End
31 Aug 2022
Estimated
—
CPV
33600000
Awarded to 27 suppliers
BI
IP
Lot 2cancelled
CM/PHR/20/5598/02 - NHS Framework LONDON Branded Medicines – Annual Tranche.
Award value
—
Start
31 Aug 2021
End
31 Aug 2022
Estimated
—
CPV
33600000
Awarded to 18 suppliers
Lot 3cancelled
CM/PHR/20/5598/03 - NHS Framework SOUTH of England Tranche A.
Award value
—
Start
31 Aug 2021
End
31 Aug 2023
Estimated
—
CPV
33600000
Awarded to 18 suppliers
AL
IP
Lot 6cancelled
CM/PHR/20/5598/06 - NHS Framework Midlands & East and NofE – Bevacizumab
Award value
—
Start
31 Aug 2021
End
28 Feb 2022
Estimated
—
CPV
33600000
Awarded to 5 suppliers
Lot 5cancelled
CM/PHR/20/5598/05 - NHS Framework SOUTH of England Annual Tranche.
Award value
—
Start
31 Aug 2021
End
31 Aug 2022
Estimated
—
CPV
33600000
Awarded to 19 suppliers
UC